Restless Legs Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 70 years old
- If you are a patient (not a healthy volunteer): you have been diagnosed with idiopathic Restless Legs Syndrome (RLS) based on your medical history and meeting 5 specific RLS diagnostic criteria (confirm with trial site)
- You have a normal result on a standard clinical (physical) examination
- You are covered by a social security or health insurance scheme
- You are willing and able to give your free, informed, written consent to take part before the study begins
Who may not be able to join:
- You have a significant mental health condition or mood disorder (such as severe depression or anxiety)
- You have a history of, or currently experience, chronic pain unrelated to RLS, epilepsy, a serious head injury, nerve damage (peripheral neuropathy), or diabetes
- You have significant sleep apnoea, narcolepsy, or your RLS is caused by another medical condition such as kidney failure or pregnancy
- You have another serious active illness, such as an unstable heart condition or cancer, that could affect your participation or the study results
- You are unable to have an MRI scan — for example, if you have a pacemaker, metal implants, clips, artificial heart valves, ear implants, metal fragments in your body or eyes, or if you experience claustrophobia or do not wish to have an MRI
- You are pregnant or currently breastfeeding
- You are under a legal protection order, deprived of liberty, or otherwise unable to give your own consent to participate (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Imad Marc Antoine GHORAYEB, MD, PhD, University Hospital, Bordeaux
Phone: (0)5.56.79.55.13
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Functional Connectivity (FC) of the anterior and posterior insular cortex (IC) measured at rest.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.